Evolution of the Average Target: Leidos Holdings, Inc.

Evolution of the Target Price: Leidos Holdings, Inc.

Changes in Analyst Recommendations: Leidos Holdings, Inc.

7855010145882bee54d6293cd0830.HPtxDlZ75AB7PtmshePbqo64Xff1cZrRCjj7q123Vu4.ZcoUaxlWvFAdboCY47OvnrfoBJGMH6iBTm-c4BrkA90viCU8HCqIORl1vg~d4589d30963abebb4f58c2b9c5746068
07-10 Baird Adjusts Price Target on Leidos to $125 From $195 MT
07-10 Truist Cuts Price Target on Leidos Holdings to $160 From $195, Keeps Buy Rating MT
07-10 Analyst recommendations: Cubesmart, Fox Corporation, AMD, Crowdstrike, Micron… Zonebourse
07-07 TD Cowen Adjusts Price Target on Leidos Holdings to $115 From $160 MT
07-07 Analyst recommendations: Ferguson, Medpace, Biogen, Crowdstrike, Take-Two… Zonebourse
07-01 Jefferies Adjusts Price Target on Leidos Holdings to $110 From $140, Keeps Hold Rating MT
07-01 Citigroup Adjusts Price Target on Leidos Holdings to $138 From $178, Maintains Buy Rating MT
06-30 UBS Adjusts Price Target on Leidos to $124 From $204, Maintains Neutral Rating MT
06-26 Argus Adjusts Price Target on Leidos Holdings to $180 From $225, Maintains Buy Rating MT
06-17 Leidos' Healthcare Business Sees Limited Future Upside From Increasing Competition, BofA Securities Says MT
06-17 BofA Securities Downgrades Leidos to Neutral From Buy, Cuts Price Target to $125 From $200 MT
06-17 BofA No Longer Rates Leidos a Buy, Shares Slide Zonebourse
06-17 BofA Downgrades Leidos Holdings to Neutral From Buy, Cuts Price Target to $125 From $200 MT
06-17 BofA Downgrades Leidos Holdings to Neutral From Buy, Price Target is $125 MT
06-03 Jefferies Downgrades Leidos to Hold From Buy, Adjusts Price Target to $140 From $185 MT
05-27 BNP Paribas Initiates Leidos Holdings at Outperform With $165 Price Target MT
05-11 Goldman Sachs Adjusts Price Target on Leidos Holdings to $171 From $180 MT
05-06 Leidos Stock Continues to Face Pressure Over Uncertainty of Health, Defense Portfolios, RBC Capital Markets Says MT
05-06 TD Cowen Adjusts Price Target on Leidos Holdings to $160 From $175 MT
04-20 Truist Lowers Price Target on Leidos Holdings to $195 From $220, Keeps Buy Rating MT
04-13 TD Cowen Adjusts Price Target on Leidos Holdings to $175 From $190, Maintains Hold Rating MT
04-08 Jefferies Adjusts Leidos Price Target to $185 From $215, Maintains Buy Rating MT
02-23 Jefferies Cuts Its Target on Leidos Holdings Zonebourse
02-23 Jefferies Adjusts Price Target on Leidos Holdings to $215 From $230, Maintains Buy Rating MT
02-18 Leidos' Revenue, Margins Could Improve in 2027 Despite Headwinds, RBC Says MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
+2.57%
+11.89%
+32.46%
+20.32%
+40.98%
+24.74%
+36.43%
+38.26%
+11.56%
Average +24.36%
Weighted average by Cap. +17.24%
See all sector consensus

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
107.02USD
Average target price
165.27USD
Spread / Average Target
+54.43%
High Price Target
225.00USD
Spread / Highest target
+110.24%
Low Price Target
110.00USD
Spread / Lowest Target
+2.78%

Analyst Consensus Detail

Consensus revision (last 18 months)

Analysts covering the company

Baird
Truist Securities
TD Cowen
Jefferies & Co.
Citigroup
UBS
Argus
BofA Securities
BNP Paribas
Goldman Sachs
RBC Capital Markets
Stifel Nicolaus
JPMorgan Chase
Morgan Stanley
Cantor Fitzgerald
Wells Fargo Securities
William Blair & Co.
Melius Research
Barclays
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
107.02USD
Average target price
165.27USD
Spread / Average Target
+54.43%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. LDOS Stock
  4. LDOS * Stock
  5. Consensus Leidos Holdings, Inc.